BDBM489618 4-(4-amino-8-fluoro- 6,7-dimethoxy- quinazolin-2-yl)-1- ((R)-3-(ethylamino)- 3-(4-fluorophenyl)- propanoyl)piperidine- 3-carboxylate::US10961252, Cmp No. 7::US11248000, Cmp No. 7

SMILES CCN[C@H](CC(=O)N1CCC(C(C1)C(=O)OC)c1nc(N)c2cc(OC)c(OC)c(F)c2n1)c1ccc(F)cc1

InChI Key InChIKey=CYSLORUADOXWBK-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 489618   

TargetComplement factor B(Human)
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489618(US10961252, Cmp No. 7 | 4-(4-amino-8-fluoro- 6,7-d...)
Affinity DataIC50: 1.00E+4nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/4/2021
Entry Details
Go to US Patent

TargetCobra venom factor/Complement factor B/Complement factor D(Monocled cobra)
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489618(US10961252, Cmp No. 7 | 4-(4-amino-8-fluoro- 6,7-d...)
Affinity DataIC50: 1.00E+4nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
Go to US Patent